<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Increasing use of longer-acting dihydropyridines</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Increasing use of longer-acting dihydropyridines</h1>
<div class="graphic"><div class="figure"><div class="ttl">Increasing use of longer-acting dihydropyridines</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAZoAAAEYCAMAAABSoMCCAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAflBMVEX////s8PHAwMBAQECAmcz/BAQgczmAgIAAM5kAAAAXFxdBZ7PM18+Rup1TkmYwMDAzgEpwcHC8yuXf4eD/OTlmhcKyz7qgoKCwsLBwpYAURKFQUFD/yMiQkJD/7e3/XFz/fHxfYGDQ2eyQptP/mZmCsJCgs9n/sLDIMEAMS3Vq1WL2AAATRklEQVR42uydi3aiMBCGE0Ag4Q6CgtZLq/bs+7/gTgJ4qWCVoiaQOVUUouvm459MQiYgpEyZMmXKlClTpkyZMmXKlClTpkyZMmXKlClTVhnWmGGEZ9YMw/u59ZGcNsreaBphpqGA6CRAKCIBpUm9UfZm1cwISeZkgRZkjglFHySqNqp23m1bskUWsdhDIzroSK82oCmLm6Yq6S2WgGhuo9EtVUtvEw13XxH5cKG9Ad9WbeoSlkJzbln2ujggYdKhGoUXlMwXZFZvFJomC/0X0dPL5n5GCQUWbkBodNyMEM3vleqZptsDvX5sTGh+rVQcmmbeAz2F5kH7vVL3Jhj+Mz2F5tFe3q+VihkZ0/c8L3Mrwx3oKTSPWkulYtfNPC/3/dCsbM/flnbcGVY7SnquQtOnaHil5lc4oM5z0InrJm5FwWvsIZYqKtGYmULTo+X1yX+B47yEXwuk/Utu0lNoulldqbnbNrKb1b7rhibuoKfQPGq/V2oGbUxprS3JPfQUmkd7m71U6h30FJoOleqHL6tUheYhS0zZLh+OBQ0OM6TQiBkG5EihEXMowMcKjZhRQCgfmXGgSUIXKTRChgB+28AKdn8w8/eXbpD91Xz9TKHp2/LWEGD/swtq+pdDCCg7UsWv7hKNAI3X3tCUl3Cwl+V+kjHFMDTwhvHI/DzkaODwHhTD0GRQMk/YMd9TaP5sbtja18xMLzQxG/r0zTAMQUGAJjPzvbmHjQ8HmXBcM/R8M3FND96F8Adi2+fPH30ePJrkRl8zN3EOPMpK5xtAAzuRH5Ybs94PEKtS7BGGnmf+cfYGnrGqvzUdffBoLhv2y9oBtYRQxZdoquo/bdh+9wKNyYbj/hYUuJToFN2cjj50NPmNk9szcw+cVnKJxjM98Gl8Uzu03D06NI4GvJmb/c2hUcKCipvT0QeO5mZf02dTBaDduESD9qGZY4i4ofmp2xozPLo99sAQIIR/QuMSSgFLy5znMaBJ+pgz5j6hxddIoAVkNt7p6Djso1L/iCaB9n6Or1SjMyYt09FHgEaA4Wa85fln1Lpqa+YB0UY7Hd0TYLiZUgt8qrs95WZUsgn4PPSRTkfPQgGuawbV2eEuVJfzrr7mCx3a1QuFBt/oa770d0AUMOvkWAeLJveF+BnQ62dRgKvQnEIAQa5rbunWsuBJoTn1NQWZ2lR2TixdoTn2NUWZ2qRUI15fU7U1jSbS1CYVoV32NUWa2pRoWrd2b4BohJrahHXm0HSs0KBbU5veYRGhuk47Ldc0PDS5ULObdQ4lUsGzQH3NyhbBTNNmwUKhuTW16S0255dryFyhES+NRtvq+rbTonMDQVOvDCTIcLMKnk9WrQwkyHCzCp7P2v5yZSAB02jGHjxXKwMlpnhpNGMPnsuVgfqZ2qSC515FUy5xImQm7ciD53JlIFPMTNpRB8/1ykB7mX40v6fA4JM4XrrcUjebXUVo3M0NPYnjtcstdehwgm31azRMNQNP4iiXW2KpMiJmoFtlGNCARl9oo0jicEX1ZhqFLqdOr9AsrC2hyRiSOHxhFwfivc3GyU460UaQxCGsaNh6qvXThZgCpho8giQO35PsBycBIYE7giQOV8bVgUYxGiCfaEaDZpiiGQQasUUTwXmTjPR6jeCi0amm0ZFer8nFbml4MJaMEg0WvaWJSLd7bcqPRnDRoAWxLDLKq5zYFFw0izl0/keJJhd9AWd8fBoZGtFFM7t6MRo0oouGWPzUSRb62NAI39JYhC4sa0HofGxohG9pULKl0K+xOpxBcqMRXjR/EpzUaLwcKTRqIEChUaIZAhosxQ02XBd9zMaGxvNl+JVBZI1uOrocokFE04PFyMbQ5BANInMSjWzRLUlEgxaEzEamGklEg5JFhPWGtsZlidHDTOKQ8v5nZ2QosQaaxJFJIho2QbMhUwCgAJphJnFIc3daSnRdv5ocYNGozBIYXhJHFsryS2nTnA2XzK12NHJnCshzS+eoaUnUMiNqkHfikEc0SG/KSks0bUu2yRCTOCS6D3qkN7U1iDuzASZxSCSa7iYnGolEg/CC0PHM3nRlEo1O9IBYY0HjSyQaxC4IjGZlJ6lEg6gFPm0sw5ty5QdGI1rZSbb8wA990YWMjGiGmVQ7BDRyiUZ327qcA0Qjl2iI1jhQM0g07qCnBUqNJpetpWEDyNEYgmfZ5tImFtUtKxiDQ5NNNFq5VN0IBmqky9rAWrDVtE4zTCRDk0s4AR13IyMZGhlTnWbgz4LhZ0DLKBpKrYgM/papUuYHUm0MFwVkFA2yIk3bLjq0NzKhkTOpVm9Z6XlQaOTMD5zxSWXWoFfbwKMZPZMOjZSiabso4H7w7I13JHHERm1xH1+XZQhLmbXRdlGg2vmOJA7Drs3o4+tCX5pUpztbIJQQ8p4kjn7ReKaZyZrqpDfHZtrbkjh6RcPuIBjKKpqWFNuZDvp4SxJHr2j2ot446B6LSMvcgHfdiaNPNNUdBCVF0xgGaIEVEdJ7EsfvwReODeeIpkiN+G8dkvIOgrL2ahINYe3nb2eLP7PV63pO4rglCICSAhUnPaFJqz3XgO4MsOs7CEo6/SxYIExfNPLcjOYIpUTwo9CPow85PQnuIHi7Z9MaCjwdzf3VfhtfW29T6DsI/m70A6FXTUc/1Wgad3FWDU7vJpp9ef9AMe8g+LttSRCQ2avRNEK5N+w6DxV+ieKkzg/E29dlpfUWF9/9RX6GpDY3eQWazy+neDUaV2bRIH07J8R9MhqGpXC+0lej6WNa4HK5Qit4bKbwej3dnY7Ant10Wb+bbho/vdnsVvAdYCv+vKz33RGhzXUa9BA8t7beFZbP5zg0++vmYEAPnc3JZI2Wkw3abdjrzfJ0ZDqBWj7W8WbX8OH1ZDKdTKAkbDcTbrBvOp1M7wqe6baP4Lmx2s+wPNBTfASNU6Tt1d/LJTSozWWFZgf1i1br6Rr4fE+h2jmazW7HFANodpvvNTsG4iqRwQdgyw7CF6yW8BZkw7Csdvd0OSn52D4DzQ8svdoZY+w4rf9EL1cD2Gn/DTULGoHzfrripz/6LjebyZJJaT3ZQTkmjik/tt6A1LhovitJTZi7K6kwAX3f8y9rNEhY36ZXNM/EcmVp0aLBfhY+m0zhZC/RsOrfQb1PJ8v1ZFXCWrKdwKtEw73cerJh2LjLA5Gwl2dogNxkUpJ7lrWicV6IpdRQkT4xci7VcEQDethsNquKQoUGXaABkGCVWFbLH2hWzJ2V5H6LnANobXpVzUuxlL7TcfDTImeozuUZGqje7+VmCXX9XTu06fLo0DgaENbym8tixeIG1iStJ7wNYmiWkx1rdO5qa6gWPSsMeFm/OS0+nxI5l2iYi6rRQPvPWpwVb1eqtoaRO0PD2qTKYwET9pJHaLVq+K47g2fNkh0NQl9XUfTLZmzepYBuw5v6vI+LAm9Ggz5/RtEvm3z2NDR8wUBNfjToZxQt+ZLBzHpabaPnmX1/jqIz+SefRVFXuYk3sfZwFkXLPuYM1mkkQFA0Z1G03GPOlT+jnfIEBJ2Ofoyi8wGsFDS0hVDKKFrIXKf7ezSV8jWtW3a6qEkcPIoWMW2D9VJZ1/N+NheZGbUlH9ZHhySOOMYIwyN1uN8/nEVPDjqcglsn7fBfu/dDLIoWMXJel9dr7h/ZZKsIUrfJzQWPJ3HYtoNi6NgcoG9TFOdhtGNDeH10Msahw38NvvveKPqfiJHzpLZ7P0AW2pxeTXaaY0yJ9nASB3Q44wrNwS4MaJWdFKQSO05RojEOX47B0RyMmPcR4bnqxsesMHyCva/KfaZMegwkPBiasjQrdHtu4L90AGiCtimClCQPJ3HYTlEwNKCR1C4cXDhGUYCOYGMjw46RXaQOtNNQyw4ct/mxtJQDK+UALyO106ochl3gCdlxm2+q0iDItLjVfobNY9GSoYl0y9L16/D5o0sSh+0cbKdEw2ryy04Nx44dG7M9HI2DcFnLrAg8oDTDxl0ea9zQAZg4VblPIPSFz9BUpYsiNW7VPETOjWPRkqFpSU7nK3A8nMTBa++ExgA0hoErChUadIXGMKrWiDUTdhrbR6HE4AidH2ig9CfsLtrZlJHz180ZHTKEATx4vgqfFwR6otrDSRzc55zQfNpOHKefhm3EtUNz4rR2aJzGFy9SdkjS2GAiO3AMrFycxjE4xMJO0xJNVdo5gBLbRVFFzlD43aN657aryDwQPDcHB+UqaY8mcbDzOz2hgXgZYjYMsimObQ3UMzpDg8BBVaEXvCriT5AJw8DLYfbxT3QAB1aJpywNu4sbMV4VOb99LPxHd3P5v70zXE9UB8IwhFY2KS2l2sKp2i3WdXfv/wZPgkGpgktCJow482N52seO2bwQPobJjOkjp7VZPXL2FcD9hfK51TFnTGhWi8WHv29Di6aOOSNC87vK2jC1uVc0HuwQc8aD5vP+t82fRSJjk0JziDljQfOxWKzsZlhwqcamg+YYc25stBr1NjPgzp9EU3opcIw5N3LWX8cLDWzvt7Z/mktFvJxQk5RjzLlx1VzIi4bXzNZ/LC+ZKVWsbWRrNO81nXnRmDVzsk6ndK9pZGt8y/HpyotGqJkb6jlfTude052tMUIs2lIzH2zJOZ/OveZCtobvWLS1Zj6iKQu7swkjmsvZGl5j0SsH0bKQndeouVY0/8jW2Lx7U9EDNPNRPHPO0qk05PpXtkboSUUP0swHE6lg8URkQI88Zy8q2lGcmbOITaVwfZ885x28ih6qmQ9XTZnGYhoLWr88Z3AVPVQzH6xQeWjzSaDpmecMq6KHa+bGudaWvXmNaPrnOQOq6JWXN8zXhsYgzxlMRbvQzPX82vbhQIjGJM/ZtYrWGRlONHP9VBNFkZgGGsMdgk5VtN4EcO82NyPMOM+mEA0w3SHoMhZtnP3XS6AJHrWqgCppcIxOHKDKGUhFG+fM9rC1vGTatj4lcbXIjdGJA1Y5n6joLzf7tiHQdMmAqPrdKJ04oJXzdxXtJusGAg3rasdVbQkYpRMHuHJu2h1eNN3MLqCBbfcAr5zdowGRARfRjNKJw4dydoxmdb8A0M5demfNUxa67sSBRzk7RbO633rbBKA3RDHXnTgQKeczNK9DyCCLi2BCY11bo5Hh+f4VWpL5DAiNW+V8sqC9PPx43diQ+RkQGtfK+fReIx9BH0wLGnws8JHBhMa+tsZpFbfdg9nrApRkEKFxWpVu8/rj4eW6ySBC47gqXfj13lMSICWDBw1AVbp+kgArGTxoQKrS9ZAEaMmgQQNWlW4vCTrLveIlgwYNYFU6JQm62rIhJoMGDWhVOikJ2tF8eK3RcJ1ooOs5dwRAfyImgwUNdD3ndjSoySBBA17PubWX6CkZBKXh8aEBr+fc1oH37JpBVUQKCRr4es4tfav/LCzbhd8UGvh6zuezrq4Zq3bht4UGvp7z2aw3VjPDduE3hcZDJ5TTO/y5NjNpF347aPx3QmnfC9Do4WfdEH5KaN7e/HdC+WzfpdFA86oKWJ/z8SqvR0fz/OS9E8q2Y//M9xvSZnfOx6tQGBvN42zmuxNKF5m2id/s7lTr2LuXzc2hCZ9nsyckZDqXK6UQ3uUit9vAoqk32+BA82vm66qpMzO3lrsB93xA0ejNNjjQhIrMzEcDoboj0HbQPk3Qq0ZvtkGC5r8KzbOHy6beBTBsBy0oGr2jAweaZLY3DxLNzd4ZT2j0Jo4oHs+eNJpn+K86oBnkBTReoDfbXEbTh5eDz5Sz2krw7+qN5qKfv5Bo6s02Fxe0Pqucg8+8/Xp8fCyf5D8J+Hf1XtAu+tHy+u8DSDRAb7bBgMbnZ3pvBnQ1HqBHzgmi6d1Ok9B4/0z1yPnnI7geNIzdCBrfn/HJiz5j9BkyMjIysrYFVNfnqkKfRRzPm8eBfizcBCGbHx0dD3k48D+W73vJmw+oxY98hGfg2UD7+lxhylNV9ankqeCs+jFlw/3og9lELFWkTzuq/Z280bAakHIQmxf4bfWjfo6g0ezrc6kImwrjcB6qGGhZBduG+9EHI6uavdaO9OH0jYbxgFSBnpLngbwgl4YDavUTZBweTV0EKpNjUKe5SNNQDkKepPPhfvTB8GFYzZ12dDh8f6NhPCAmp1Q7KHk+3A/jsS80c3kSqKVnLa9Xkcgzl5WqwfdQP/pggUY70gd7NPWAhFpalYPEdGFs8xOKjPlCI1fUXHA57khOZyQHEBh/dYuf2p0FGu1IH45vNCwHFMzX66W66+XC+Cpu8cOsazgb3eWq+lxBLu++mXpzUKjLpeRxaXiStvmp3ZnNhPwLNYeVo6O/b280jAcUFPLKS9UtQ2RxPthPyJj8LbRE0/W5dONV9eagDINwyXnmwI8+mMoAzoPaUcNfPmRA0X4gkfnZ3uonCHwsaGRkZGRkZGRkIxpTEc2EzWkm0JmKeoRChDQT6CwUvIjl034YR6prchZFZRKwOMnphe/oVnChHtZTEac8CUScCSEvJcFjmprRTT5zJyr0VgWIWBYJLtEUNC8YhEDViIKrvGNW8GWRKjS0nKFBEwiRs3Ue87gQhAYXmmTJuSjClAtCQ0ZGRkZGRkZGRkZGRkZGRkZGRkbmzf4H0FJ8pvCxt/cAAAAASUVORK5CYII="/></div><div class="graphic_lgnd">Introduction and growth of new prescriptions of differing formulations of nifedipine and of amlodipine since 1986. Nifedipine was only available in the United States as a short-acting formulation in the late 1980s. The slow-release GITS (gastrointestinal therapeutic system) formulation of nifedipine was not introduced until 1989, and its usage did not increase appreciably until 1991-1992; the usage of amlodipine began to increase in 1993.</div><div class="graphic_reference">Data from Epstein, M, Am J Hypertens 1996;9:110.</div><div id="graphicVersion">Graphic 51498 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
